Etheros Pharmaceuticals Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Etheros Pharmaceuticals General Information

Description

Developer of small-molecule drugs designed to mimic endogenous enzymes for neuroprotection and healthspan improvement. The company platform offers compounds that prevent oxidative and inflammatory injury and extend lifespan, enabling healthcare researchers to advance in treating neural sensitivity and promoting longevity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 111 10th Avenue South
  • Suite 110
  • Nashville, TN 37203
  • United States
+1 (615)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 111 10th Avenue South
  • Suite 110
  • Nashville, TN 37203
  • United States
+1 (615)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Etheros Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-Dec-2025 Completed Generating Revenue
1. Early Stage VC 01-Mar-2023 Completed Generating Revenue
To view Etheros Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Etheros Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Backed Venture Capital Minority
Immortal Dragons Venture Capital Minority
Healthspan Capital Venture Capital Minority
VitaDAO Venture Capital Minority
To view Etheros Pharmaceuticals’s complete investors history, request access »

Etheros Pharmaceuticals FAQs

  • When was Etheros Pharmaceuticals founded?

    Etheros Pharmaceuticals was founded in 2022.

  • Where is Etheros Pharmaceuticals headquartered?

    Etheros Pharmaceuticals is headquartered in Nashville, TN.

  • What industry is Etheros Pharmaceuticals in?

    Etheros Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Etheros Pharmaceuticals a private or public company?

    Etheros Pharmaceuticals is a Private company.

  • What is Etheros Pharmaceuticals’s current revenue?

    The current revenue for Etheros Pharmaceuticals is .

  • Who are Etheros Pharmaceuticals’s investors?

    Backed, Immortal Dragons, Healthspan Capital, and VitaDAO have invested in Etheros Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process